Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review

被引:3
|
作者
Ge, Qichao [1 ,2 ]
Liu, Yang [1 ,2 ]
Yang, Fan [1 ]
Sun, Guangwei [3 ]
Guo, Jintao [1 ]
Sun, Siyu [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gastroenterol, 36 Sanhao St, Shenyang 110004, Peoples R China
[2] China Med Univ, Innovat Res Ctr Integrated Canc Om, Shengjing Hosp, Shenyang 110004, Peoples R China
[3] China Med Univ, Shengjing Hosp, Innovat Engn Technol Res Ctr Cell Therapy, Shenyang 110022, Peoples R China
基金
中国国家自然科学基金;
关键词
gastrointestinal stromal tumor; whole-exome sequencing; germline mutation; familial disease; precision oncology; GERMLINE MUTATION; KIT; SUNITINIB; IMATINIB; REGORAFENIB; MULTICENTER; EFFICACY; FAILURE; SAFETY; GENE;
D O I
10.3390/ijms24010830
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder with only a few affected families reported to date. Here, we report a case of familial GISTs harboring a novel germline mutation within exon 18 of KIT. A 58-year-old male patient presented with gastric subepithelial lesions accompanied by cutaneous hyperpigmentation, which were subsequently diagnosed as multinodular GISTs. Endoscopic surgery was initially conducted to remove the larger lesions, and pathological examinations were then conducted for the diagnosis of GISTs. Family history revealed that some other family members had similar cutaneous pigmentations. Whole-exome sequencing was used to search for potential driver mutations, and Sanger sequencing was used for mutation validation. A novel primary driver mutation of KIT (c.G2485C, p.A829P) was detected in these hereditary GISTs, which has been reported in some targeted chemotherapy-resistant GISTs. Cell models were subsequently established for the rapid screening of candidate drugs and exploring potential mechanisms. This mutation could lead to cell proliferation and imatinib resistance by ligand-independent activation of KIT; however, ripretinib administration was identified as an applicable targeted therapy for this mutation. The mutation activated the JAK/STAT3 and MAPK/ERK pathways, which could be inhibited by ripretinib administration. To the best of our knowledge, this is the first report of the KIT-A829P mutation in familial GISTs, complementing the pathogenesis of familial GISTs and providing valuable information for the precision treatment of this disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] A lethal mesenteric gastrointestinal stromal tumor: a case report and review of the literature
    Xu, Lijun
    Wen, Ge
    Ding, Yanqing
    Zhao, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11715 - 11721
  • [22] Gastrointestinal Stromal Tumor of the Adrenal Gland:A Case Report and Review of the Literature
    Hussam Abou Al-Shaar
    Shrouq Solimanie
    Ayman Azzam
    Tarek Amin
    Ahmed Abu-Zaid
    Endocrine Pathology, 2015, 26 : 27 - 32
  • [23] A Case Report of Multiple Gastrointestinal Stromal Tumors: Imaging Findings, Surgical Approach, and Review of the Literature
    Tarallo, Mariarita
    Carruezzo, Cristina
    Di Accadia, Filippo Maria Dentice
    Del Gaudio, Antonella
    Caruso, Damiano
    Polici, Michela
    Crocetti, Daniele
    Costi, Umberto
    Polistena, Andrea
    Panzuto, Francesco
    Laghi, Andrea
    Cavallaro, Giuseppe
    Fiori, Enrico
    FRONTIERS IN SURGERY, 2022, 9
  • [24] Complete response of advanced rectal gastrointestinal stromal tumors after imatinib treatment: A case report and literature review
    Wu, Tingting
    Cheng, Xiaobin
    Chen, Wenbin
    MEDICINE, 2022, 101 (32) : E29411
  • [25] Familial gastrointestinal stromal tumors with KIT germline mutation in a Chinese family: A case report
    Yuan, Wei
    Huang, Wen
    Ren, Lei
    Xu, Chen
    Luan, Li-Juan
    Huang, Jie
    Xue, An-Wei
    Fang, Yong
    Gao, Xiao-Dong
    Shen, Kun-Tang
    Lv, Jing-Huan
    Hou, Ying-Yong
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (15) : 4878 - 4885
  • [26] Synchronous occurrence of gastrointestinal stromal tumor and acute myeloid leukemia: A case report and review of the literature
    Gao, Na
    Guo, Nong-Jian
    Yu, Wen-Zheng
    Wang, Xue-Xia
    Sun, Jian-Rong
    Yu, Ning
    Liu, Ren-Tong
    Liu, Xiao-Dan
    Liu, Zeng-Yan
    Feng, Rui
    ONCOLOGY LETTERS, 2016, 11 (05) : 2977 - 2980
  • [27] Gastrointestinal stromal tumor of the prostate: a case report and literature review
    Lee, Chii-Hong
    Lin, Yun-Ho
    Lin, Hsiao-Yu
    Lee, Chi-Ming
    Chu, Jan-Show
    HUMAN PATHOLOGY, 2006, 37 (10) : 1361 - 1365
  • [28] Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature
    Beltrame, Valentina
    Gruppo, Mario
    Pastorelli, Davide
    Pizzi, Sara
    Merigliano, Stefano
    Sperti, Cosimo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [29] Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: Report of a case
    Hirashima, Kotaro
    Takamori, Hiroshi
    Hirota, Masahiko
    Tanaka, Hiroshi
    Ichihara, Atsushi
    Sakamoto, Yasuo
    Ikuta, Yoshiaki
    Karashima, Ryu-ichi
    Watanabe, Masayuki
    Iyama, Ken-ichi
    Baba, Hideo
    SURGERY TODAY, 2009, 39 (11) : 979 - 983
  • [30] Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review
    Rossi, Sabrina
    Congedo, Teresa
    Ricci, Riccardo
    Martini, Maurizio
    Di Noia, Vincenzo
    Di Dio, Carmela
    Quirino, Michela
    Barone, Carlo
    Cassano, Alessandra
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (01) : E4 - E9